Stockscreener 앱 받기
143.92
2.28%
3.21
시간 외 거래:
143.92
전일 마감가:
$140.71
열려 있는:
$142.55
하루 거래량:
2.82M
Relative Volume:
1.02
시가총액:
$39.66B
수익:
$21.37B
순이익/손실:
$1.41B
주가수익비율:
36.49
EPS:
3.9437
순현금흐름:
$3.07B
1주 성능:
-0.85%
1개월 성능:
-2.51%
6개월 성능:
-26.45%
1년 성능:
-15.20%
1일 변동 폭
$141.25
$145.59
1주일 범위
$140.11
$145.60
52주 변동 폭
$140.11
$213.08
벡톤 디킨슨 Stock (BDX) Company Profile
명칭
Becton Dickinson Co
전화
(201) 847-6800
주소
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
143.92 | 39.67B | 21.37B | 1.41B | 3.07B | 3.9437 |
ISRG
Intuitive Surgical Inc
|
403.18 | 144.07B | 10.58B | 3.00B | 2.83B | 8.2437 |
ALC
Alcon Inc
|
66.12 | 31.54B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
35.30 | 30.39B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
191.26 | 27.36B | 5.54B | 1.52B | 1.74B | 10.37 |
벡톤 디킨슨 Stock (BDX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-10 | 재개 | Goldman | Neutral |
| 2026-02-10 | 재개 | Barclays | Overweight |
| 2026-02-03 | 재개 | Citigroup | Buy |
| 2025-09-25 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Goldman | Buy → Neutral |
| 2025-05-02 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-05-01 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2023-07-24 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-05-05 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | 업그레이드 | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2022-12-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2022-07-11 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2022-06-24 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 재개 | Raymond James | Mkt Perform |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2021-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 개시 | Barclays | Equal Weight |
| 2020-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 재개 | Goldman | Buy |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-07 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-02-07 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | 다운그레이드 | Cowen | Outperform → Market Perform |
| 2020-01-08 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2019-05-13 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 개시 | Deutsche Bank | Buy |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-06-21 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-04-10 | 업그레이드 | Citigroup | Neutral → Buy |
| 2018-01-19 | 재개 | BofA/Merrill | Buy |
| 2018-01-05 | 업그레이드 | Citigroup | Sell → Neutral |
| 2018-01-05 | 개시 | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 개시 | Evercore ISI | Outperform |
| 2017-12-29 | 재확인 | Deutsche Bank | Buy |
모두보기
벡톤 디킨슨 주식(BDX)의 최신 뉴스
Becton Dickinson (BDX) Issues Voluntary Recall for Select Skin Preparation Products - Insider Monkey
Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Becton Dickinson and Co (BDX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Becton Dickinson and Co (BDX) Institutional Confidence - TradingKey
Becton Dickinson and Co (BDX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Becton Dickinson and Co (BDX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Becton Dickinson and Co (BDX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Becton Dickinson and Co (BDX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Becton Dickinson and Co (BDX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Becton Dickinson and Co (BDX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Becton Dickinson & Co. stock underperforms Wednesday when compared to competitors - MarketWatch
Deals tracker: Baptist Health acquires Arkansas hospital - Modern Healthcare
BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177 - Moomoo
Becton Dickinson and Co Stock (US0758871091): Valuation Check As Shares Lag 2026 Highs - AD HOC NEWS
Is Becton, Dickinson and Company (BDX) A Good Stock To Buy Now? - Yahoo Finance
Becton Dickinson & Co Stock (US0758871091): Stock in focus after a quiet news day - AD HOC NEWS
BofA Securities Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Cuts Target Price to $170 - Moomoo
Becton Dickinson EVP Michael Garrison sells $166,628 in stock - Investing.com UK
Tranche Update on Becton, Dickinson and Company's Equity Buyback Plan announced on January 27, 2026. - marketscreener.com
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Becton Dickinson & Co (BDX) Revenue BreakdownMain Composition - Moomoo
Becton, Dickinson and Company: - marketscreener.com
Becton, Dickinson and Company (BDX) Stock Analysis: Unpacking a 19.89% Potential Upside - DirectorsTalk Interviews
Jim Cramer on Becton, Dickinson: “I Think You Buy Some and Then You Wait” - insidermonkey.com
Becton Dickinson earnings loom as investors eye post-divestiture growth By Investing.com - Investing.com
Is It Smart To Buy Becton, Dickinson and Company (NYSE:BDX) Before It Goes Ex-Dividend? - Yahoo Finance
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
June 3, 2026Polen Thomas E Jr - Becton Dickinson
Becton Dickinson chairman, CEO Thomas E. Polen Jr. sells $404k in shares - Investing.com UK
Becton Dickinson & Co Insider Sold Shares Worth $404,511, According to a Recent SEC Filing - Moomoo
June 2, 2026Menziuso Peter3 - Becton Dickinson
Becton Dickinson & Co. stock outperforms competitors despite losses on the day - MarketWatch
Becton Dickinson & Co stock (US0758871091): Norges Bank stake highlights interest after recent earni - AD HOC NEWS
Becton, Dickinson And Company (BDX) Stock Analysis: Exploring A 23% Upside Potential - DirectorsTalk Interviews
TD Cowen Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $163 - 富途牛牛
Becton Dickinson resumes U.S. shipments of ChloraPrep after additional testing - TradingView
Here’s Hinde Group’s Updates on Becton, Dickinson and Company (BDX) - Insider Monkey
Piper Sandler Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $161 - Moomoo
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Becton Dickinson EVP Michael Feld sells $11,051 in stock - Investing.com UK
Becton Dickinson EVP Michael Feld sells $11,051 in stock By Investing.com - Investing.com UK
Goldman Sachs Adjusts PT on Becton, Dickinson and Co. to $150 From $156, Maintains Neutral Rating - Moomoo
Becton, Dickinson And Company (BDX): Evaluating Growth Potential With A 24% Upside - DirectorsTalk Interviews
벡톤 디킨슨 (BDX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.44%
자본화:
|
볼륨(24시간):